Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xbrane Biopharma AB (publ) | 17,351 | net | 13 Mar 2024 | tx 9+17,351 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Mar 2024 | PURCHASE | Xbrane Biopharma AB (publ) | 3,479 | 11.50 SEK | |
| 05 Sept 2023 | GRANT_AWARD | Xbrane Biopharma AB (publ) | 3,000 | 0.00 SEK | deriv |
| 05 Sept 2023 | OTHER | Xbrane Biopharma AB (publ) | 3,000 | 0.22 SEK | |
| 13 Jun 2023 | PURCHASE | Xbrane Biopharma AB (publ) | 1,869 | 80.09 SEK | first after silence |
| 01 Jun 2022 | GRANT_AWARD | Xbrane Biopharma AB (publ) | 3,003 | 68.80 SEK | |
| 16 Jun 2021 | GRANT_AWARD | Xbrane Biopharma AB (publ) | 1,500 | 167.60 SEK | |
| 16 Nov 2020 | PURCHASE | Xbrane Biopharma AB (publ) | 377 | 70.60 SEK | |
| 16 Nov 2020 | PURCHASE | Xbrane Biopharma AB (publ) | 58 | 70.20 SEK | |
| 16 Nov 2020 | PURCHASE | Xbrane Biopharma AB (publ) | 1,065 | 70.60 SEK |
1 purchase reported after at least 12 months of silence — most recent on 13 Jun 2023.